# US 2023/0055512 A1 · Method of treatment of topical dermatologic acne using a cream composition and method of manufacture

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0055512 A1
- Document ID: US20230055512A1
- Status: Published application
- Kind: A1
- Application number: 17/901,688
- Filed: 2022-09-01
- Published: 2023-02-23
- Earliest claimed: 2019-01-15
- Assignees: Derma Research Group, Inc.
- Applicants: Derma Research Group Inc.
- Inventors: Dusan Sajic; Maksym Breslavets; Scottpatrick Sellitto
- Web page: https://patentgrep.com/patent/US20230055512A1

## CPC

- A61K 31/327: Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
- A61K 8/347: {Phenols}
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 8/37: Esters of carboxylic acids
- A61K 8/671: {Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal}
- A61K 8/675: {Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde (tocopheryl nicotinate A61K8/678)}
- A61K 8/891: saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/095: Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K 31/145: having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2) (isothiourea A61K31/155)
- A61K 31/194: having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
- A61K 31/25: with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
- A61K 31/455: Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A61K 31/65: Tetracyclines
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 31/7056: containing five-membered rings with nitrogen as a ring hetero atom
- A61K 33/30: Zinc; Compounds thereof
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/58: Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
- A61K 36/61: Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
- A61K 36/742: {Coffea, e.g. coffee}
- A61K 36/82: Theaceae (Tea family), e.g. camellia
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61P 17/10: Anti-acne agents
- A61Q 17/005: {Antimicrobial preparations}
- A61Q 19/00: Preparations for care of the skin
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

In some aspects, the techniques described herein relate to a topical dermatologic acne treatment method using a cream. The treatment method uses two steps, first providing a bactericidal component and second providing a skin revitalizing complex. The bactericidal component clears the acne causing bacteria. The subsequent skin revitalizing complex revitalizes and conditions the skin and aids in return of natural skin flora and microbiome to prevent subsequent outbreaks. The skin revitalizing complex can include a variety of components such as: niacinamide, retinol, bakuchiol, green coffee bean extract, green tea extract, epilobium fleischeri extract, citric acid, dimethicone, and pentaerythrityl tetracaprylate. The skin revitalizing complex restores natural elasticity and oil production of the skin, decrease sebum production, and provide necessary conditioning of the skin to provide for the natural skin flora and microbiome to repopulate and flourish on a surface of the skin.

## Claims

### Claim 1

A topical dermatologic acne treatment method using a cream comprising:
a) providing a bactericidal component; and
b) providing a skin revitalizing complex;
wherein in a first stage of the method, the provided bactericidal component clears the acne causing bacteria, and in a second stage of the method, the skin revitalizing complex revitalizes and conditions the skin and aids in return of natural skin flora and microbiome to prevent subsequent outbreaks.

### Claim 2 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1 wherein the skin revitalizing complex comprises:
a) niacinamide;
b) retinol;
c) bakuchiol;
d) green coffee bean extract;
e) green tea extract;
f) epilobium fleischeri extract;
g) citric acid;
h) dimethicone; and
i) pentaerythrityl tetracaprylate;
wherein elements of the skin revitalizing complex restores natural elasticity and oil production of the skin, decrease sebum production, and provide necessary conditioning of the skin to provide for the natural skin flora and microbiome to repopulate and flourish on a surface of the skin.

### Claim 3 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1, wherein said bactericidal component comprises benzoyl peroxide.

### Claim 4 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1, wherein said bactericidal component comprises clindamycin.

### Claim 5 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1, wherein said bactericidal component comprises erythromycin.

### Claim 6 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1, wherein said bactericidal component comprises minocycline.

### Claim 7 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1, wherein said bactericidal component comprises dapsone.

### Claim 8 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1, wherein said bactericidal component comprises sulfur.

### Claim 9 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1, wherein said bactericidal component comprises tea tree oil.

### Claim 10 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1, wherein said bactericidal component comprises zinc salts.

### Claim 11 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1, wherein said bactericidal component comprises Hydroxytyrosol.

### Claim 12 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1 wherein said cream is adapted for use as a treatment of actinic keratosis.

### Claim 13 (depends on 1)

The topical dermatologic acne treatment method using a cream of claim 1 wherein said cream is adapted to reduce topical dermatologic scarring.

### Claim 14

A method using a topical dermatologic acne treatment cream comprising of:
providing in a first step a treatment of presenting acne through use of an active ingredient adapted to act as an antibacterial agent;
providing in a second step a dermatologic acne treatment cream to condition skin which underwent the first step by providing a acne treatment cream which comprises:
a) micro encapsulated benzoyl peroxide at 2.5% w/w;
b) niacinamide at 2.0% w/w;
c) retinol at 0.5% w/w;
d) bakuchiol at 0.5% w/w;
e) green coffee bean extract at 0.5% w/w;
f) green tea extract at 0.5% w/w;
g) epilobium fleischeri extract at 0.5% w/w;
h) citric acid at 0.1% w/w;
i) dimethicone at 1.0% w/w;
j) pentaerythrityl tetracaprylate at 2.0% w/w; and
k) hydroxytyrosol at 0.5% w/w.

### Claim 15 (depends on 14)

The method using a cream of claim 14 further comprising neem oil.

### Claim 16 (depends on 14)

The method using a cream of claim 14 wherein said cream is used for the treatment of actinic keratosis.

### Claim 17 (depends on 14)

The method using a cream of claim 14 wherein said cream is adapted to reduce topical dermatologic scarring.

### Claim 18 (depends on 14)

The method of using a cream of claim 14 wherein said antibacterial agent comprises minocycline.

### Claim 19 (depends on 14)

The method of using a cream of claim 14 wherein said antibacterial agent comprises zinc salts.

### Claim 20 (depends on 14)

The method of using a cream of claim 14 wherein said antibacterial agent comprises Hydroxytyrosol.
